Now, a DIGITAL PILL is is trackable too!

Washington, Nov 14: The US Food and Drug Administration (FDA) has approved the first drug in the US with a digital ingestion tracking system that can tell doctors whether the medication was taken.

It has an ingestible sensor embedded in the pill that records that the medication was taken.

The product, Abilify MyCite (aripiprazole tablets with sensor), was approved on Monday for the treatment of schizophrenia, bipolar disorder and for use as an add-on treatment for depression in adults.

The system works by sending a message from the pill's sensor to a wearable patch. The patch transmits the information to a mobile application so that patients can track the ingestion of the medication on their smartphone, the FDA said in a statement.

Patients can also permit their caregivers and physician to access the information through a web-based portal.

"Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," said Mitchell Mathis, Director of the Division of Psychiatry Products in the FDA's Center for Drug Evaluation and Research.

Schizophrenia is a chronic, severe and disabling brain disorder. Typically, symptoms are first seen in adults younger than 30 years of age.

Symptoms of those with schizophrenia include hearing voices, believing other people are reading their minds or controlling their thoughts, and being suspicious or withdrawn.

Bipolar disorder, also known as manic-depressive illness, is another brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks.

The approval of the so-called digital pill is expected to increase adherence to medication.

Prior to initial patient use of the product, the patient's health care professional should facilitate use of the drug, patch and app to ensure that the patient is capable and willing to use the system, FDA said.

"The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers," Mathis said.


Related news

Don’t Miss

100 Left organisations will hold protest against Modi govt in state capitals
Farm income to double by 2022, says PM Modi
LIVE: Country is tired of what is happening under current government: Rahul
Xi re-elected as China's President after removal of term limit
WhatsApp introduced this new FEATURE that you always WANTED
Beant Singh Assassination: Quantum of sentence to be announced
Ankita Lokhande's Manikarnika FIRST look goes viral
12th passout and looking for a job? Apply here and get 85K/month
Congress Plenary: Highlight Modi's failures, plan path for next five years
Good news: Vacancies in BHEL; Salary will be Rs 50,000
SpiceJet Hyderabad-Bengaluru flight veers off runway
US is India's 2nd biggest arms supplier, Israel 3rd, says report
This country is India's 2nd biggest arms supplier: Report
Rs 2000 notes will NOT be discontinued, says government
Venkaiah Naidu urges MPs to not disrupt, Congress hits back
Top 5 songs of Daler Mehndi
Audi India to hike vehicle prices by this much
Microsoft offers $250,000 to identify chip bugs
Angry Karan Patel hits back at trolls
Six dead in Florida university footbridge collapse
Ex Karnataka DGP makes an insensitive statement about Nirbhaya's mom
Good news: Samsung Galaxy S9, S9+ now available here
Revealed: Irrfan Khan is suffering from Neuro Endocrine tumour
Irrfan Khan diagnosed with this disease
Don't miss these THUNDER deals on smartphones
Why Andhra Pradesh wants a special status catgory from the center?
Center makes it clear to SC: Will not damage Ram Sethu for shipping channel project
LG lauds AAP's initiatives in education, healthcare
Kejriwal has 'murdered' AAP in Punjab: Sidhu
After conviction, Daler Mehndi granted bail by Patiala Court

Most Recent